Non Hodgkin Lymphoma News and Research

RSS
ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

Study finds increasing incidence of cancer among adolescents and young adults

Study finds increasing incidence of cancer among adolescents and young adults

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Study uses a statistical approach to reveal patterns of cancer incidence

Study uses a statistical approach to reveal patterns of cancer incidence

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Breast cancer simulation models can guide screening recommendations for women

Breast cancer simulation models can guide screening recommendations for women

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Scientist explore potential drugs to prevent cell resistance in different types of cancer

Scientist explore potential drugs to prevent cell resistance in different types of cancer